Searched for
BRONCHOSPASM TREATMENT
Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...- Pope Francis in stable condition, continues to receive medical carePope Francis remains in stable condition, responding well to non-invasive mechanical ventilation and high-flow oxygen therapy. He has no fe...
- Pope Francis, in setback, had 'isolated' breathing crisis, Vatican saysPope Francis experienced an isolated breathing crisis and vomiting with aspiration in Gemelli hospital on Friday, with a sudden worsening o...
- US unit of India's Cipla recalls six batches of bronchospasm inhalerIndian pharmaceutical company Cipla has recalled six batches of its Albuterol Sulfate HFA Inhalation Aerosol in the US due to a container d...
- Lupin inks pact to acquire two inhalation brands from Sunovion for USD 75 mnThe acquisition of these two brands will expand the company's inhalation product portfolio in the US and strengthen its presence in the res...
- Lupin gets US health regulator's approval for asthmatic symptoms prevention drugThe approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin sai...
- The Week That Was in 10 Stocks: Pharma shares on a tear; IDBI, IndusInd Bank rallyA second stimulus package India is poised to announce in coming days will be worth around Rs 1 lakh crore.
- Market Movers: M&M, Maruti, Cipla soar; 19 stocks turn ‘overbought’As many as 19 stocks turned ‘overbought’ as they crossed the 70 mark on RSI indicator.
- Cipla hits 15% upper circuit as USFDA gives final approval to Albuterol Inhalation AerosolFollowing the development, the scrip hit its 15 per cent upper circuit limit at Rs 589.95.
- Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation AerosolIn a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfa...
- World Asthma Day: Long-term usage of inhalers can have adverse side effectsNot only prevalent in developed countries, but it is also a major problem in the developing countries.
- FDA approves Merck's new lung drug DuleraMerck & Co Inc's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Th...
- Local cos line up for Merck unitThe bidding process for the generics business of German pharmaceutical corporation Merck is set to begin in a few days. The advisors to Mer...
Load More
